Apoptosis, inflammatory bowel disease and carcinogenesis: Overview of international and Greek experience, Pulsus Group Inc
CANADIAN JOURNAL OF GASTROENTEROLOGY
The Canadian Association of Gastroenterology (CAG) Canadian Association for the Study of the Liver (CASL)

Abstract

Note: (Optional)

Citation Builder

  •  
Return to Table of Contents
 
Original Article April 2003, Volume 17 Issue 4: 249-258
 

Apoptosis, inflammatory bowel disease and carcinogenesis: Overview of international and Greek experience

J Kountouras | G Kouklakis | C Zavos | D Chatzopoulos | et al

Apoptosis is critical for organ development, tissue homeostasis, the elimination of abnormal cells and the maintenance of immune homeostasis by variable regulatory mechanisms. The death of T lymphocytes following their activation involves a series of proteases (caspases), which comprise the central executioners of apoptosis. Abnormal regulation of apoptosis results in disease. T-cell resistance against apoptosis contributes to inappropriate T-cell accumulation and the perpetuation of the chronic inflammatory process in inflammatory bowel disease with potential tumourigenic effect. The use of antitumour necrosis factor-alpha, anti-interleukin-6R and anti-interleukin-12 antibodies suppresses colitis activity by induction of T-cell apoptosis, thereby having important implications for the design of effective therapeutic strategies in inflammatory bowel diseases. Contrary to international data, the incidence of cancer in Greek patients with inflammatory bowel disease appears to be low. A balance between cell proliferation (Ki-67 overexpression) and apoptosis (Bax protein overexpression) may partly explain the low incidence of cancer development in Greek inflammatory bowel disease patients.

Apoptosis | Carcinogenesis | Caspases | Inflammatory bowel disease
   Français   
          
Click to download PDF Reader
 
 




Copyright © Pulsus Group Inc.